cystine has been researched along with Type 3 Von Willebrand's Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayakawa, F; Hayakawa, Y; Kanematsu, T; Katsumi, A; Kiyoi, H; Kojima, T; Matsushita, T; Mukaide, M; Odaira, K; Okamoto, S; Sanda, N; Suzuki, A; Suzuki, N; Tamura, S | 1 |
1 other study(ies) available for cystine and Type 3 Von Willebrand's Disease
| Article | Year |
|---|---|
VWF-Gly2752Ser, a novel non-cysteine substitution variant in the CK domain, exhibits severe secretory impairment by hampering C-terminal dimer formation.
Topics: Cysteine; Cystine; Humans; Protein Domains; Protein Multimerization; von Willebrand Disease, Type 3; von Willebrand Factor | 2022 |